Skip to main content
. Author manuscript; available in PMC: 2014 Nov 24.
Published in final edited form as: Sci Transl Med. 2010 Apr 14;2(27):27ra27. doi: 10.1126/scitranslmed.3000619

Table 1.

Baseline characteristics of subjects†.

All subjects Subjects requiring extra carbohydrates‡ Subjects not requiring extra carbohydrates‡

Number 11 5 6
Sex 7M / 4F 5M 2M / 4F
Age (years) 40 ± 16 (19–71) 47 ± 19 (19–71) 34 ± 13 (20–50)
BM (kg) 83 ± 13 (66–110) 90 ± 12 (79–110) 78 ± 11 (66–95)
BMI (kg/m2) 28 ± 3 (22–31) 27 ± 4 (22–31) 28 ± 3 (22–31)
Diabetes Duration (years) 23 ± 13 (6–46) 30 ± 17 (6–46) 17 ± 4 (9–21)
HbA1c (%) 7.3 ± 0.8 (6.2–8.5) 7.4 ± 1.0 (6.4–8.5) 7.3 ± 0.7 (6.2–8.1)
Daily insulin dose (U/kg) 0.6 ± 0.2 (0.3–1.0) 0.5 ± 0.2 (0.3–0.8) 0.7 ± 0.2 (0.5–1.0)
Stimulated c-peptide* (nmol/L) < 0.03 < 0.03 < 0.03
†

Results are expressed as mean ± SD (range), unless otherwise stated.

‡

Hypoglycemia was treated with extra carbohydrates (15 g) if BG remained below 60 mg/dL for a 20-minute period, below 50 mg/dL for a 10-minute period, or if subjects were symptomatic (see Supplementary Appendix).

*

All subjects had undetectable fasting and stimulated c-peptide, reported as less than the assay limit.